126,500.00
+4,000.00
+(3.27%)
At close: January 31 at 3:30:22 PM GMT+9
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
189,502,178.85
252,530,449.54
293,233,456.82
135,912,348.06
Total Liabilities Net Minority Interest
41,280,911.65
32,931,523.51
34,458,706.02
23,786,163.82
Total Equity Gross Minority Interest
148,221,267.20
219,598,926.03
258,774,750.79
112,126,184.25
Total Capitalization
148,221,267.20
219,598,926.03
267,921,750.79
115,738,184.25
Preferred Stock Equity
150,658.00
1,082,861.00
1,506,590.00
211,268.00
Common Stock Equity
148,070,609.20
218,516,065.03
257,268,160.79
111,914,916.25
Capital Lease Obligations
796,935.24
402,214.67
421,547.40
375,237.22
Net Tangible Assets
141,319,904.76
211,709,881.18
250,173,606.24
103,976,274.95
Working Capital
97,547,036.44
163,016,065.42
211,932,551.82
86,001,340.26
Invested Capital
159,917,609.20
230,363,065.03
269,115,160.79
115,526,916.25
Tangible Book Value
141,169,246.76
210,627,020.18
248,667,016.24
103,765,006.95
Total Debt
12,643,935.24
12,249,214.67
12,268,547.40
3,987,237.22
Share Issued
28,120.31
25,503.02
24,234.92
23,683.81
Ordinary Shares Number
27,980.31
25,503.02
24,234.92
23,683.81
Preferred Shares Number
301.32
2,165.72
3,013.18
422.54
Treasury Shares Number
140.00
--
--
--
12/31/2020 - 5/10/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
087010.KQ Peptron, Inc.
97,700.00
+0.31%
298380.KQ ABL Bio Inc.
36,350.00
+2.97%
196170.KQ ALTEOGEN Inc.
371,500.00
+2.62%
AKTX Akari Therapeutics, Plc
1.0900
-18.05%
OCS Oculis Holding AG
22.91
+2.51%
IGMS IGM Biosciences, Inc.
1.5100
+0.67%
BMRN BioMarin Pharmaceutical Inc.
63.36
-0.81%
VERU Veru Inc.
0.5557
-4.27%
MRNA Moderna, Inc.
39.42
-3.95%